Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease

Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease

Randomized trials of pulmonary vasodilators in pulmonary hypertension due to left heart disease (Group 2) and lung disease (Group 3) have demonstrated potential for harm. Yet these therapies are commonly used in practice. Little is known of the effects of treatment outside of clinical trials. We aim...

Full description

Bibliographic Details
Main Authors: Kari R. Gillmeyer, Donald R. Miller, Mark E. Glickman, Shirley X. Qian, Elizabeth S. Klings, Bradley A. Maron, Joseph T. Hanlon, Seppo T. Rinne, Renda S. Wiener
Format: Article
Language:English
Published: SAGE Publishing 2021-03-01
Series:Pulmonary Circulation
Online Access:https://doi.org/10.1177/20458940211001714

Similar Items

Similar Items